This trial is testing a new drug to see if it's better than placebo at treating urinary tract infections caused by E. coli.
2 Primary · 6 Secondary · Reporting Duration: Within the 6-month follow-up period
Experimental Treatment
Non-Treatment Group
580 Total Participants · 8 Treatment Groups
Primary Treatment: LBP-EC01 · Has Placebo Group · Phase 2 & 3
Age 18 - 65 · Female Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Florida | 100.0% |
18 - 65 | 100.0% |
Research Site 106 | 100.0% |
Met criteria | 50.0% |
Did not meet criteria | 50.0% |
Phone Call | 100.0% |